Skip to main content
Rachel Jankowitz, MD, Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

RachelCatherineJankowitzMD

Oncology Philadelphia, PA

Section Chief, Breast Medical Oncology Director, Rena Rowan Breast Center at the Penn Medicine Abramson Cancer Center

Dr. Jankowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jankowitz's full profile

Already have an account?

  • Office

    3400 Civic Center Boulevard
    3rd Floor, West Pavilion
    Philadelphia, PA 19104
    Phone+1 215-615-3111
    Fax+1 215-662-4000
  • Is this information wrong?

Summary

  • I am an Associate Professor in the Division of Hematology/Oncology, Section Chief of Breast Medical Oncology and Director of the Rena Rowan Breast Center at the Penn Medicine Abramson Cancer Center. My clinical practice is focused on care of patients with breast cancer. My research has centered around invasive lobular breast cancer (ILC), and I have served as PI and/or co-investigator for many breast cancer clinical trials.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2006 - 2009
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2003 - 2024
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Rachel Jankowitz, MD, on the COVID-19 Pandemic and Breast Cancer Treatment
    Rachel Jankowitz, MD, on the COVID-19 Pandemic and Breast Cancer TreatmentJune 22nd, 2021
  • New Study Details How Breast Cancer Diagnoses Could Be Prevented or Delayed
    New Study Details How Breast Cancer Diagnoses Could Be Prevented or DelayedMay 27th, 2016
  • New Method for Predicting Breast Cancer Risk Suggests About 30% of Cases Could Be Prevented
    New Method for Predicting Breast Cancer Risk Suggests About 30% of Cases Could Be PreventedMay 26th, 2016
  • Join now to see all

Professional Memberships

Hospital Affiliations